Table 2 Clinical and laboratory characteristics of PD patients in cases and controls
Variables | Cases (n = 5) | Controls (n = 15) | p |
|---|---|---|---|
Male, n (%) | 4 (80.0) | 12 (80.0) | 1.00 |
Age (years) | 66.0 ± 9.7 | 66.0 ± 7.8 | 1.00 |
BMI (kg/m2) | 25.2 ± 1.8 | 23.1 ± 2.9 | 0.154 |
Dialysis duration (days) | 11.8 [7.5–14.2] | 18.0 [8.5–46.8] | 0.22 |
Diabetes mellitus, n (%) | 4 (80.0) | 3 (20.0) | 0.031* |
Cardiovascular disease, n (%) | 4 (80.0) | 4 (26.7) | 0.109 |
Body temperature (℃) | 37.1 [36.5–37.3] | 37.0 [36.6–37.2] | 0.85 |
Systolic blood pressure (mmHg) | 145 [125–151] | 125 [108–141] | 0.29 |
Diastolic blood pressure (mmHg) | 75 [71–80] | 76 [69–83] | 1.00 |
White blood cell (/µL) | 8100 [5900–10350] | 9600 [7900–14100] | 0.176 |
Hemoglobin (g/dL) | 9.6 ± 1.4 | 11.0 ± 1.6 | 0.127 |
Platelet (× 104/µL) | 29.1 [22.7–34.3] | 20.9 [18.4–22.3] | 0.067 |
Urea nitrogen (mg/dL) | 38.9 [32.7–56.8] | 39.7 [31.3–51.0] | 0.86 |
Creatinine (mg/dL) | 9.3 ± 2.5 | 9.3 ± 3.4 | 0.79 |
Total protein (g/dL) | 5.8 ± 0.57 | 6.4 ± 0.98 | 0.23 |
Albumin (g/dL) | 2.6 [2.4–3.2] | 3.3 [2.5–3.6] | 0.20 |
Aspartate aminotransferase (U/L) | 20 [11–27] | 19 [13–24] | 0.97 |
Alkaline phosphatase (U/L) | 225 [164–348] | 261 [194–285] | 0.76 |
Lactate dehydrogenase (U/L) | 193 [173–271] | 207 [183–216] | 0.80 |
Sodium (mmol/L) | 135 [131–139] | 136 [133–140] | 0.38 |
Potassium (mmol/L) | 3.7 [3.3–4.4] | 3.5 [3.3–4.3] | 0.83 |
Corrected calcium (mg/dL) | 9.5 ± 0.47 | 9.1 ± 0.67 | 0.38 |
Phosphate (mg/dL) | 4.5 [3.3–5.8] | 4.0 [3.4–5.3] | 0.76 |
C-reactive protein (mg/dL) | 2.7 [1.1–6.7] | 0.92 [0.47–4.3] | 0.22 |
Hemoglobin A1c (%) | 6.1 ± 0.65 | 5.8 ± 0.61 | 0.64 |
Cell counts of dialysate at diagnosis of peritonitis (/µL) | 2670 [1145–8709] | 3515 [965–7900] | 1.00 |
Cell counts of dialysate after appropriate antibiotics (/µL) | 2561 [349–4654] | 20 [20–23] | 0.0006* |
β2-microgloblin (µg/L) | 29.4 [25.2–30.5] | 23.1 [20.5–30.3] | 0.38 |
Catheter removal, n (%) | 4 (80.0) | 0 (0.0) | 0.001* |